Abstract
Human eosinophils (EOSs) stimulated under optimal conditions with 5 × 10 8 unopsonized zymosan particles at 37 °C for 30 minutes produced an average total immunoreactive leukotriene (LT) C 4 of 1.6 ng per 10 6 EOSs, and 30% to 60% of the generated product remained cell associated. The dose-response characteristics of zymosan-induced LTC 4 generation were different from those of phagocytosis, suggesting that the two events were independent. Pretreatment of EOSs with 10 −8 mol/L of formyl-methionyl-leucyl-phenylalanine for 30 minutes led to a twofold to fivefold augmentation of LTC 4 generation by cells subsequently activated by unopsonized zymosan. Optimal EOS activation with 1 μmol/L of the calcium ionophore A23187 at 37 °C for 15 minutes produced more than 100 times greater quantities of LTC 4 than with zymosan. The amount of immunoreactive LTC 4 that remained cell associated after calcium ionophore A23187 stimulation reached a maximum after 5 minutes and then declined. Of the relatively small amount generated in the first minute, 71% was cell associated, but this figure declined to 9% after 15 minutes, by which time there had been a redistribution of the LTC 4 to the supernatant. Inflammatory leukocytes may respond to zymosan because the cells recognize either one or both of its major polysaccharide components, glucan and mannan. Glucan, but not mannan, stimulated EOSs to generate LTC 4 in a dose- and time-dependent manner. Under optimal conditions, there was no significant difference in the total quantities of LTC 4 elaborated by EOSs stimulated by glucan and by unopsonized zymosan. This suggests that zymosan may induce leukotriene generation in the human EOS through a glucan recognition mechanism.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.